Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
25%
OVERLAP
BY WEIGHT
22
# OF OVERLAPPING
HOLDINGS
XUHL.DE
58
HOLDINGS
38%
ALSO IN HEAL.L
HEAL.L
197
HOLDINGS
15%
ALSO IN XUHL.DE
SECTOR DRIFT (XUHL.DE minus HEAL.L)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XUHL.DE |
Weight in HEAL.L |
Overlap | |
|---|---|---|---|---|
 |
JOHNSON & JOHNSON | 10.3% | 2.3% | 2.3% |
|
MERCK & CO. INC. | 5.2% | 2.2% | 2.2% |
|
GILEAD SCIENCES INC | 3.0% | 1.9% | 1.9% |
|
BRISTOL-MYERS SQUIBB CO | 2.1% | 1.8% | 1.8% |
|
AMGEN INC | 3.3% | 1.8% | 1.8% |
XUHL.DE Overweight Relative to HEAL.L
|
ELI LILLY & CO | 15.0% |
|
JOHNSON & JOHNSON | 8.0% |
|
UNITEDHEALTH GROUP INC | 6.7% |
|
ABBVIE INC | 5.2% |
|
MERCK & CO. INC. | 3.0% |
|
CVS CAREMARK CORP | 2.3% |
|
VERTEX PHARMACEUTICALS INC | 2.1% |
|
STRYKER CORP | 1.9% |
|
MCKESSON CORP | 1.7% |
|
ABBOTT LABORATORIES | 1.7% |
XUHL.DE Underweight Relative to HEAL.L
|
MODERNA, INC. | -2.3% |
 |
UCB SA | -2.3% |
|
ILLUMINA INC | -2.1% |
 |
GSK PLC | -1.9% |
 |
NOVARTIS AG | -1.9% |
 |
GENMAB A/S | -1.9% |
 |
CELLTRION INC | -1.8% |
 |
BEIGENE, LTD. | -1.7% |
|
BIOGEN IDEC INC | -1.7% |
|
EXELIXIS INC | -1.5% |